Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Post-Operative Pain in Buccal Mucosal Graft Harvesting
NCT03720223Phase 3Completed
- Sponsor
- Urology of Virginia
- Start
- Jan 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Urology of Virginia. Primary endpoints: Post-operative Pain Score on Numerical Rating Scale, Morphine Equivalent Requirements and 1 more. Started Jan 2015; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03720223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03720223.